drugset / Trial / NCT06657105

A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

NCT06657105

Phase 1 Completed 22 enrolled AstraZeneca
Non-randomizedSequentialOpen-labelOther

Summary

The main purpose of the study is to assess the effect of multiple doses of baxdrostat on the pharmacokinetics (PK) of a single dose of combined oral ethinyl estradiol (EE) and levonorgestrel (LNG). Safety and tolerability of baxdrostat will be assessed during the study.

Timeline

Start
2024-11-01
Primary completion
2025-02-03
Completion
2025-02-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Baxdrostat Small molecule Oral
Subject Levonorgestrel Small molecule Oral
Subject ethinyl estradiol Small molecule Oral

Indications

No indication recorded.